Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours ยท Estimated delivery Aug 19 - Aug 24
NDC: 70069-0172-10
BPC-157 supports this interconnected system by: Strengthening tight junctions between intestinal epithelial cells, reducing intestinal permeability (leaky gut) Modulating the enteric nervous system to normalize motility and reduce visceral hypersensitivity Regulating mucosal immune responses to prevent inappropriate inflammation against dietary and microbial antigens Conditions Treated with Oral BPC-157 Beyond Symptom Relief: Addressing Root Causes Unlike proton pump inhibitors (PPIs) that suppress stomach acid or corticosteroids that broadly dampen immunity, BPC-157 works by restoring the underlying structural and functional integrity of the gastrointestinal tract
For people dealing with both allergies and autoimmune conditions, Ta1 offers the possibility of addressing both simultaneously through its central immune-regulatory mechanism
Pharmacokinetic studies demonstrated approximately 38% oral bioavailability and blood-brain barrier penetration, unusual for a peptide-based compound and attributable to Dihexa's small size (504.66 Da) and hydrophobic modifications
US$ 29.64
US$ 24.95
US$ 22.30
US$ 22.06
US$ 22.08
US$ 20.59
US$ 28.19
US$ 22.80
US$ 29.20
